1. Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension

   • David Montani
   • Marie-Camille Chaumais
   • Olivier Sitbon

   Review 19 September 2009 Pages: 813 - 825

2. Advances in the treatment of gastrointestinal stromal tumor

   • David D’Adamo

   Review 02 October 2009 Pages: 826 - 837

3. Improving patient acceptance and adherence in diabetes management: a focus on insulin therapy

   • Robert E. Rakel

   Review 19 September 2009 Pages: 838 - 846

4. Cost of atrial fibrillation in United States managed care organizations

   • Michael H. Kim
   • Jay Lin
   • David Battleman

   Original Research 19 September 2009 Pages: 847 - 857

5. Effect of glucosamine sulfate with or without omega-3 fatty acids in patients with osteoarthritis

   • Joerg Gruenwald
   • Ellen Petzold
   • Hans-Joachim Graubaum

   Original Research 04 September 2009 Pages: 858 - 871

6. An economic evaluation of budesonide/formoterol for maintenance and reliever treatment in asthma in general practice

   • Lucas M. A. Goossens
   • Roland A. Riemersma
   • Maureen P. M. H. Rutten-van Mölken

   Original Research 19 September 2009 Pages: 872 - 885

7. Melatonin and tryptophan circadian profiles in patients with advanced non-small cell lung cancer

   • Shilian Hu
   • Gan Shen
   • Bing Hu

   Original Research 02 October 2009 Pages: 886 - 892